More of the same, 2020 ASX losses evaporate, Harvey Norman (ASX:HVN) falls on strong profit, US markets pointing to flat open The ASX200 (ASX:XJO) weakened throughout the day finishing 0.6% higher, but has now overcome all losses sustained in 2020 and is on track for the best November in several decades. The sustained recovery on…
A big-spending budget focused on improving regional Victoria, health, housing, education, and transport infrastructure but at the same time pushing debt to eye-watering levels during a recession were the main hallmarks of the Andrews Government’s state budget. To sum it up, it is a Budget tilted towards rebuilding the state economy from the ground up….
Geoff Wilson of Wilson Asset Management fame and the Stock Brokers and Financial Advisers Association have joined with the SMSF Association in attempting to get fairer access for small investors in company capital raisings. ASIC is in their sights. In a webinar organised by the SMSF body yesterday (November 25), coinciding with SMSF Week, Geoff…
Stock market volatility is arguably one of the most misunderstood concepts in investing, especially for new investors trying to dip their toes in. Put simply, stock market volatility is a term used to describe fluctuations in the market, which may refer to factors like stock prices, the volume of trading or the amount of investors participating…
There has been somewhat of a Cold War between the industry and self-managed sectors of Australia’s superannuation environment over the last decade. Words have been exchanged on a near daily basis, discussing with a particular focus on SMSFs coming at a significantly higher cost than the alternatives and requiring a substantial amount of input from…
The Dow Jones was the latest index to join the all-time high club in 2020, breaching 30,000 points this week. Despite being owned by Standard & Poor’s the index is regularly seen as the poorer cousin of the S&P 500 or tech focused Nasdaq Composite. Why is that the case? Despite being around since 1896…
Rhinomed (RNO, 17.5 cents)Market capitalisation: $44 millionThree-year total return: +4.1% a yearAnalysts’ consensus valuation: n/a The Melbourne-based Rhinomed is a specialist in respiratory airway technology: it is a world-leading developer of nasal devices made from ultra-soft medical-grade bio-compatible polymers, that helps the volume of air travelling through the nose. The company has brought to market three kinds of…
This year’s Sohn Hearts & Minds Conference, an annual one-day event that brings the finance and investment community together, saw a select group of fund managers fund manager share their best stock idea for the year ahead. This year’s recurring theme without doubt was COVID-19. But grief and tragedy aside, COVID-19 has forced us to…
